In vivo magnetic resonance spectroscopy (MRS)/imaging (MRI) has recently been extensively used in investigating the physiology and metabolite alterations of both murine and human neoplasms. It was found that the 31P and 1H MRS are informative in tumor membrane metabolism and bioenergetics, and could potentially be the clinical monitor and/or predictor of tumor response to treatments. However, due to the diversity and complexity of the tumors, the understanding of these alterations from the conventional tumor biochemistry points of view is generally poor and immediate exploration is needed. An extensive correlative study into the physiology and biochemistry of tumor characteristics and their alterations in response to irradiation using both phosphorous and hydrogen MRS in situ and vitro is proposed. In brief: (a) The variation of MRS-observed metabolites and pH of various subpopulations with different ratios of host/tumor cells, Q/P cells, hypoxic fractions, and cell cycle phase distributions will be analyzed and correlated; (b) The effects of subpopulation on intrinsic radioresistance will be examined using MRS in order to elucidate the biological factors which cause the radiation-induced alteration in the metabolites; (c) Ultimately, the significance of in vivo MRS parameters as clinical monitors and/or predictors will be deduced.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA047227-03
Application #
3190744
Study Section
Diagnostic Radiology Study Section (RNM)
Project Start
1988-04-01
Project End
1992-03-31
Budget Start
1990-04-01
Budget End
1991-03-31
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Baldwin, N J; Ng, T C (1996) Oxygenation and metabolic status of KHT tumors as measured simultaneously by 19F magnetic resonance imaging and 31P magnetic resonance spectroscopy. Magn Reson Imaging 14:541-51
Baldwin, N J; Wang, Y; Ng, T C (1996) In situ 19F MRS measurement of RIF-1 tumor blood volume: corroboration by radioisotope-labeled [125I]-albumin and correlation to tumor size. Magn Reson Imaging 14:275-80
Czerski, L; Majors, A; Ng, T C et al. (1993) Growth and magnetic resonance characteristics of human squamous cell carcinoma xenografts implanted with cells suspended in Matrigel. NMR Biomed 6:297-301
Vijayakumar, S; Czerski, L; Majors, A et al. (1992) Phosphorous metabolite and cell cycle kinetic response of two human squamous cell carcinomas to radiation. Cancer Res 52:5299-306
Sijens, P E; Ng, T C (1992) Thymidine-modulated 5-fluorouracil metabolism in liver and RIF-1 tumors studied by 19F magnetic resonance spectroscopy. Magn Reson Imaging 10:385-92
Sijens, P E; Baldwin, N J; Ng, T C (1991) Multinuclear MR investigation of the metabolic response of the murine RIF-1 tumor to 5-fluorouracil chemotherapy. Magn Reson Med 19:373-85
Sijens, P E; Huang, Y M; Baldwin, N J et al. (1991) 19F magnetic resonance spectroscopy studies of the metabolism of 5-fluorouracil in murine RIF-1 tumors and liver. Cancer Res 51:1384-90
Majors, A W; Ng, T C; Karalis, I M et al. (1990) Phosphorus metabolites and the distribution of cell cycle phase of RIF-1 tumors in response to 14 Gy irradiation. Magn Reson Med 16:425-30
Xue, M; Ng, T C; Majors, A (1990) Spectral editing of tumor 13C MRS in situ. Magn Reson Med 14:530-7
Majors, A W; Ng, T C; Xue, M et al. (1989) Monitoring therapeutic response of human superficial tumors using phase-encoded spectroscopy. Magn Reson Med 12:369-78